INSIGHTS ON DRUG DEVELOPMENT
-
Scale-Up Of An Adherent rAAV Production Process
Fixed-bed bioreactors simplify the scale-up of viral vector production. Discover a system that bridges development and manufacturing with data confirming consistent performance across scales.
-
Scale-Up Of A Transient rAAV Production Process
Scalable rAAV production is achievable with a transient cell line and optimized bioreactor setup, delivering high titers and reduced impurities, now validated at 200 L scale for commercial readiness.
-
Cracking Complexity: Leveraging Lessons Learned For Future Bispecific Development
The shift from static platforms to adaptive, knowledge-driven development helps biopharma teams manage BsAb complexity, accelerate analytical, purification, and formulation development, and improve IND readiness.
-
Flying On Two Wings: Balancing Local Agility And Global Quality In China
As China expands its role in drug development, injectable therapy programs face new demands. Learn how manufacturers are scaling quality, devices, and production for global success.
-
Advancing Infectious Disease Research With This ddPCR System3/26/2026
Efficient digital PCR workflows maximize data from 5µL samples. Achieve high-level multiplexing and faster turnaround times to accelerate discovery and verify NGS findings with total confidence.
-
Patented Process For Intermediates Useful For Etrasimod Arginine3/13/2026
Explore how rethinking the synthetic strategy for Etrasimod can overcome the limitations of legacy routes, enabling more efficient chirality control, improved scalability, and more practical industrial API production.
-
Biofluorescent Particle Counters Are Gaining Momentum4/28/2025
The 2025 BioPhorum report highlights challenges and trends in drug filling operations and how they are advancing towards biofluorescent particle counters. Discover an approach that aligns with industry needs.
-
Ask Us Anything: Cy Credille7/24/2026
Learn how we balance discovery and development as an asset scales, and how the One Cambrex model keeps the original process scientists attached to a molecule from first kilos through NDA.
-
A Digital Dispenser For Single-Cell And Low-Input Proteomics11/7/2025
Discover a high-precision dispensing system that enables rapid, low-volume sample prep for single-cell proteomics to support flexible workflows, maintain cell integrity, and deliver reliable results.
DRUG DEVELOPMENT SOLUTIONS
-
By harnessing cutting-edge microcalorimetry technology, researchers can unravel the complexities of molecular interactions, paving the way for groundbreaking discoveries in drug development.
-
Used Elizabeth Hata R&D tablet press, model EP200, B/D tooled with 10 station turret, 5 stations each B and D, 16 mm B, 22 mm D max tablet diameter, 17 mm B, 18 mm D max depth of fill, rated up to 6000 tablets/hour, with feed hoppers and feed frames, Machine #81, built 2011.
-
This pipeline outlines a sequence of late‑stage and emerging therapeutics projected to launch between 2024 and 2031, spanning immunology, neurology, psychiatry, rare disease, oncology, and inflammatory disorders.
-
Everything we do for our customers is driven by an unswerving belief that ideas need to become solutions, molecules need to become cures, fast. Because humanity needs solutions, fast.
-
The Thermo Scientific™ DXR3 Flex Raman Spectrometer is a research-grade Raman spectrometer specifically designed for integration with other analytical techniques.